期刊的影响因子--文章列表

期刊文章列表
Xuan Li¹，Shicheng Fan^1,2，Chenghui Cai¹，Yue Gao¹，Xinhui Wang³，Yifei Zhang¹，Hangfei Liang¹，Huilin Li¹，Jie Yang¹，Min Huang¹，Huichang Bi^1,2（Guangdong Provincial Key Laboratory of New Drug Design and Evaluation，School of Pharmaceutical Sciences，Sun Yat-sen University；NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening，School of Pharmaceutical Sciences，Southern Medical University；School of Pharmaceutical Sciences(Shenzhen)，Sun Yat-sen University）.YAP regulates the liver size during the fasting-refeeding transition in mice[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoqing Liu，Shuang Liang，Xiao Sang，Lili Chang，Shunli Fu，Han Yang，Huizhen Yang，Yongjun Liu，Na Zhang（Department of Pharmaceutics，Key Laboratory of Chemical Biology（Ministry of Education），NMPA Key Laboratory for Technology Research and Evaluation of Drug Products，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University）.On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition[J].Acta Pharmaceutica Sinica B,2023,第4期 Yan Shi¹，Candy Lee²，Peng Sang¹，Zaid Amso²，David Huang²，Weixia Zhong²，Meng Gu¹，Lulu Wei¹，Van T.B.Nguyen-Tran²，Jingyao Zhang¹，Weijun Shen²，Jianfeng Cai¹（Department of Chemistry，University of South Florida；Calibr at Scripps Research）.α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2023,第4期 Dan Gao¹，Sajid Asghar²，Rongfeng Hu³，Su Chen¹，Ruixin Niu¹，Jia Liu⁴，Zhipeng Chen⁵，Yanyu Xiao¹（State Key Laboratory of Natural Medicines，China Pharmaceutical University；Faculty of Pharmaceutical Sciences，Government College University Faisalabad；Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application；Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine；Department of Pharmacy，Nanjing University of Chinese Medicine）.Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Nasir Uddin^1,2,3，Daniel W.Binzel^1,2,3，Dan Shu^1,2,3，Tian-Min Fu⁴，Peixuan Guo^1,2,3（Center for RNA Nanobiotechnology and Nanomedicine，Division of Pharmaceutics and Pharmacology，College of Pharmacy，the Ohio State University；Dorothy M.Davis Heart and Lung Research Institute，the Ohio State University；James Comprehensive Cancer Center，College of Medicine，the Ohio State University；Department of Biological Chemistry & Pharmacology，College of Medicine，the Ohio State University）.Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome[J].Acta Pharmaceutica Sinica B,2023,第4期 Yichen Zhong^1,2，Shi Du^1,2，Yizhou Dong^1,3,2（Division of Pharmaceutics & Pharmacology，College of Pharmacy，The Ohio State University；Icahn Genomics Institute，Precision Immunology Institute，Department of Oncological Sciences，Tisch Cancer Institute，Friedman Brain Institute，Icahn School of Medicine at Mount Sinai；Department of Radiation Oncology，Department of Biomedical Engineering，Center for Clinical and Translational Science，Comprehensive Cancer Center，Dorothy M. Davis Heart & Lung Research Institute，Center for Cancer Engineering，Center for Cancer Metabolism，Pelotonia Institute for Immune-Oncology，The Ohio State University）.mRNA delivery in cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Shuo Han^1,2，Xinru Chen¹，Leaf Huang¹（Division of Pharmacoengineering and Molecular Pharmaceutics，Eshelman School of Pharmacy，University of North Carolina at Chapel Hill；Department of Toxicology，Guangdong Provincial Key Laboratory of Tropical Disease Research，School of Public Health，Southern Medical University）.The tumor therapeutic potential of long non-coding RNA delivery and targeting[J].Acta Pharmaceutica Sinica B,2023,第4期 Yang Liu¹，Wei Xu²，Mingxue Li¹，Yueying Yang¹，Dejuan Sun¹，Lidian Chen³，Hua Li^1,2，Lixia Chen¹（Wuya College of Innovation，Key Laboratory of Structure-Based Drug Design & Discovery，Ministry of Education，Shenyang Pharmaceutical University；Institute of Structural Pharmacology & TCM Chemical Biology，College of Pharmacy，Fujian University of Traditional Chinese Medicine；The Institute of Rehabilitation Industry，Fujian University of Traditional Chinese Medicine）.The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer[J].Acta Pharmaceutica Sinica B,2023,第4期 Ramya Dhandapani，Swaminathan Sethuraman，Uma Maheswari Krishnan，Anuradha Subramanian（Centre for Nanotechnology ＆ Advanced Biomaterials，School of Chemical ＆ Biotechnology，SASTRA Deemed University）.Self-assembled multifunctional nanotheranostics against circulating tumor clusters in metastatic breast cancer[J].Acta Pharmaceutica Sinica B,2023,第4期 Shaowei Bing^1,2，Senfeng Xiang²，Zhimei Xia²，Yilong Wang^1,3，Zhonghai Guan^1,3，Jinxin Che^2,4，Aixiao Xu²，Xiaowu Dong^2,5,4，Ji Cao^2,5,4，Bo Yang²，Jinhu Wang^1,5,3，Qiaojun He^2,5,4，Meidan Ying^1,2,5,3（Department of Surgical Oncology，Children's Hospital，Zhejiang University School of Medicine；Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；Pediatric Cancer Research Center，National Clinical Research Center for Child Health；Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center，Zhejiang University）.AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells[J].Acta Pharmaceutica Sinica B,2023,第4期 Lu Su^1,2，Kellie S.Dalby¹，Hannah Luehmann³，Sussana A.Elkassih¹，Sangho Cho¹，Xun He¹，Lisa Detering³，Yen-Nan Lin¹，Nari Kang¹，Dennis A.Moore⁴，Richard Laforest³，Guorong Sun¹，Yongjian Liu³，Karen L.Wooley¹（Department of Chemistry，Department of Materials Science and Engineering，and Department of Chemical Engineering，Texas A&M University；Laboratory of Macromolecular and Organic Chemistry and Institute for Complex Molecular Systems，Eindhoven University of Technology；Mallinckrodt Institute of Radiology，Washington University School of Medicine；Bayer AG）.Ultrasmall, elementary and highly translational nanoparticle X-ray contrast media from amphiphilic iodinated statistical copolymers[J].Acta Pharmaceutica Sinica B,2023,第4期 Changjun Lv¹，Minghui Sun²，Yilei Guo¹，Wenxin Xia¹，Simiao Qiao¹，Yu Tao¹，Yulai Fang¹，Qin Zhang¹，Yanrong Zhu¹，Yusufu Yalikun²，Yufeng Xia¹，Zhifeng Wei¹，Yue Dai¹（Department of Pharmacology of Chinese Materia Medica，School of Traditional Chinese Pharmacy，China Pharmaceutical University；Division of Sports Medicine and Adult Reconstructive Surgery，Department of Orthopedic Surgery，Nanjing Drum Tower Hospital，the Affiliated Hospital of Nanjing University Medical School）.Cholinergic dysfunction-induced insufficient activation of alpha7 nicotinic acetylcholine receptor drives the development of rheumatoid arthritis through promoting protein citrullination via the SP3/PAD4 pathway[J].Acta Pharmaceutica Sinica B,2023,第4期 Juan Pang¹，Jia Nuo Feng^2,3,4，Wenhua Ling¹，Tianru Jin^2,3,4（Division of Nutrition，School of Public Health，Sun Yat-sen University；Banting and Best Diabetes Centre，Faculty of Medicine，University of Toronto；Dept. of Physiology，University of Toronto；Division of Advanced Diagnostics，Toronto General Hospital Research Institute，University Health Network）.Commentary：Can FXR serve as a potential target for COVID-19 prevention?[J].Acta Pharmaceutica Sinica B,2023,第4期 Wei Tao（Center for Nanomedicine and Department of Anesthesiology，Brigham and Women’s Hospital，Harvard Medical School）.Editorial of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications[J].Acta Pharmaceutica Sinica B,2023,第4期 Sheng Chen^1,2，Tailin He²，Yiming Zhong²，Mingjue Chen²，Qing Yao²，Di Chen³，Zengwu Shao¹，Guozhi Xiao²（Department of Orthopaedics，Union Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Biochemistry，School of Medicine，Shenzhen Key Laboratory of Cell Microenvironment，Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research，Southern University of Science and Technology；Research Center for Human Tissues and Organs Degeneration，Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences）.Roles of focal adhesion proteins in skeleton and diseases[J].Acta Pharmaceutica Sinica B,2023,第3期 Tian-guang Zhang，Chao-yu Miao（Department of Pharmacology，Second Military Medical University/Naval Medical University）.Mitochondrial transplantation as a promising therapy for mitochondrial diseases[J].Acta Pharmaceutica Sinica B,2023,第3期 Mengnan Zhao¹，Rujing Wang¹，Kunmeng Yang²，Yuhong Jiang³，Yachen Peng^4,5，Yuke Li¹，Zhen Zhang¹，Jianxun Ding⁴，Sanjun Shi¹（State Key Laboratory of Southwestern Chinese Medicine Resources，School of Pharmacy，Chengdu University of Traditional Chinese Medicine；The First Norman Bethune College of Clinical Medicine，Jilin University；School of Life Science and Engineering，Southwest Jiaotong University；Key Laboratory of Polymer Ecomaterials，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences；Department of Orthopedics，China-Japan Union Hospital of Jilin University）.Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis[J].Acta Pharmaceutica Sinica B,2023,第3期 Yanfang Yang¹，Ke Feng²，Liying Yuan¹，Yuxin Liu¹，Mengying Zhang³，Kaimin Guo³，Zequn Yin⁴，Wenjia Wang³，Shuiping Zhou^5,6，He Sun^3,5,6，Kaijing Yan^3,5,6，Xijun Yan^5,6，Xuerui Wang⁴，Yajun Duan^4,7，Yunhui Hu³，Jihong Han^1,4（College of Life Sciences，State Key Laboratory of Medicinal Chemical Biology，Key Laboratory of Bioactive Materials of Ministry of Education，Nankai University；Department of Physiology，Binzhou Medical University；Cloudphar Pharmaceuticals Co.Ltd.；Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes，Hefei University of Technology；The State Key Laboratory of Core Technology in Innovative Chinese Medicine，Tasly Academy，Tasly Holding Group Co.Ltd.；Tasly Pharmaceutical Group Co.Ltd.；Department of Cardiology，the First Affiliated Hospital of USTC，Division of Life Science and Medicine，University of Science and Technology of China）.Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms[J].Acta Pharmaceutica Sinica B,2023,第3期 Xiaoqing Fan，Chutian Mai，Ling Zuo²，Jumin Huang，Chun Xie^3,4,5，Zebo Jiang⁶，Runze Li⁷，Xiaojun Yao，Xingxing Fan，Qibiao Wu，Peiyu Yan，Liang Liu⁷，Jianxin Chen²，Ying Xie⁷，Elaine Lai-Han Leung^3,4,5（Dr.Neher’s Biophysics Laboratory for Innovative Drug Discovery，State Key Laboratory of Quality Research in Chinese Medicine，Macau University of Science and Technology；Beijing University of Chinese Medicine；Cancer Center；Faculty of Health Science；MOE Frontiers Science Center for Precision Oncology，University of Macau；Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging，the Fifth Affiliated Hospital，Sun Yat-sen University；State Key Laboratory of Dampness Syndrome of Chinese Medicine，the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)）.Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice[J].Acta Pharmaceutica Sinica B,2023,第3期 Qian Zhou¹，Meiling Le¹，Yiyi Yang¹，Wenjuan Wang²，Yuqi Huang¹，Quan Wang¹，Yijing Tian¹，Meiyan Jiang¹，Yong Rao^2,3，Hai-Bin Luo^1,2,3，Yinuo Wu¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute，School of Pharmaceutical Sciences，Hainan University；Song Li' Academician Workstation of Hainan University (School of Pharmaceutical Sciences)）.Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia：Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis[J].Acta Pharmaceutica Sinica B,2023,第3期 Lei Zhang^1,2,3，Biwei Ye^1,3，Zhuo Chen^1,2,3，Zhe-Sheng Chen（State Key Laboratory of Structural Chemistry，Fujian Institute of Research on the Structure of Matter，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Fujian Agriculture and Forestry University；Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John’s University）.Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers[J].Acta Pharmaceutica Sinica B,2023,第3期 Senlin Li^1,2，Siyu Chen³，Zhihui Dong¹，Xingdong Song²，Xiuling Li¹，Ziqi Huang²，Huiru Li²，Linzhuo Huang¹，Ganyuan Zhuang¹，Ran Lan²，Mingyan Guo⁴，Wende Li³，Phei Er Saw¹，Lei Zhang²（Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Guangdong-Hong Kong Joint Laboratory for RNA Medicine，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Department of Hepatobiliary Surgery，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Guangdong Laboratory Animals Monitoring Institute，Guangdong Key Laboratory of Laboratory Animals；Department of Anesthesiology，Sun Yat-sen Memorial Hospital，Sun Yat-sen University）.Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer[J].Acta Pharmaceutica Sinica B,2023,第3期 Xing Duan¹，Yi Zhang²，Mengran Guo²，Na Fan¹，Kepan Chen¹，Shugang Qin¹，Wen Xiao¹，Qian Zheng¹，Hai Huang¹，Xiawei Wei¹，Yuquan Wei¹，Xiangrong Song¹（Department of Critical Care Medicine，Department of Clinical Pharmacy，Frontiers Science Center for Disease-related Molecular Network，State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University；West China Hospital，Sichuan University）.Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhuo Feng¹，Yuchen Wang¹，Haiheng Xu¹，Yunfei Guo¹，Wen Xia¹，Chenxuan Zhao¹，Xiaozhi Zhao²，Jinhui Wu^1,3（State Key Laboratory of Pharmaceutical Biotechnology，Chemistry and Biomedicine Innovation Center，Medical School of Nanjing University；Department of Andrology，Drum Tower Hospital，Medical School of Nanjing University；Jiangsu Key Laboratory for Nano Technology，Nanjing University）.Recent advances in bacterial therapeutics based on sense and response[J].Acta Pharmaceutica Sinica B,2023,第3期 Minxuan Xu^1,2,3，Jun Tan^1,2，Liancai Zhu³，Chenxu Ge^1,2,3，Wei Dong⁴，Xianling Dai^1,3，Qin Kuang^1,3，Shaoyu Zhong^1,2，Lili Lai^1,2，Chao Yi^1,2，Qiang Li^1,2，Deshuai Lou^1,2，Linfeng Hu^1,2,3，Xi Liu^1,2，Gang Kuang^1,2，Jing Luo^1,2，Jing Feng³，Bochu Wang³（Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region，School of Biological and Chemical Engineering，Chongqing University of Education；College of Modern Health Industry，Chongqing University of Education；Key Laboratory of Biorheological Science and Technology (Chongqing University)，Ministry of Education，College of Bioengineering，Chongqing University；Shandong Cancer Hospital and Institute，Shandong First Medical University & Shandong Academy of Medical Sciences）.The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhe Chen^1,2，Chaoyang Meng^1,3，Junhua Mai¹，Yongbin Liu¹，Hangwen Li⁴，Haifa Shen^1,5（Department of Nanomedicine，Houston Methodist Academic Institute；Xiangya Hospital of Central South University；Department of Hepatobiliary and Pancreatic Surgery，First Affiliated Hospital，Zhejiang University School of Medicine；Stemirna Therapeutics；Immuno Q Therapeutics）.An mRNA vaccine elicits STING-dependent antitumor immune responses[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhihui Dong^1,2，Zhuoshan Huang^1,2，Senlin Li^1,2，Ying Wang^1,2，Yandan Yao^1,2，Xianzhu Yang³，Xiaoding Xu^1,2（Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Medical Research Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；RNA Biomedical Institute，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；School of Biomedical Sciences and Engineering，South China University of Technology，Guangzhou International Campus）.Nanoparticles（NPs）-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第3期首页上一页 7 8 9 10 11 下一页尾页共有12页，转到页

期刊文章列表